SWOG clinical trial number
SWOG-9110

A Phase II Evaluation of Didemnin B In Central Nervous System Tumors

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Didemnin B in CNS tumors
Activated
11/01/1991
Closed
11/15/1993

Research committees

Brain Cancer

Publication Information Expand/Collapse

1999

Phase II study of didemnin B in central nervous system tumors: A Southwest Oncology Group study.

SA Taylor;DJ Giroux;KA Jaeckle;TJ Panella;SR Dakhil;SC Schold Investigational New Drugs 16:331-332

1994

Phase II trial of didemnin B (DNB) in patients (pts) with recurrent or residual malignant gliomas

SA Taylor;C Upchurch;C Schold Annals of Oncology 5(Suppl.5)(#280)